Common Questions Asked Regarding c-Met in RCC

Common Questions Asked Regarding c-Met in RCC

User Photo
AnnualMeeting2017

3 years
788 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Aly-Khan Lalani, MD of Dana-Farber Cancer Institute summarizes the common questions colleagues ask him concerning his study on c-Met expression in renal cell carcinoma. This was recorded at the 2017 ASCO Annual Meeting in Chicago, IL.

Abstract 4573: Differential expression of c-Met between primary and metastatic sites in clear-cell renal cell carcinoma (ccRCC) and its association with PD-L1 expression
Up Next Autoplay
>